Retrospective Study Comparing Two Palliative Hypofraction Radiotherapy Protocols to Advanced Breast Cancer | ||
| Zagazig University Medical Journal | ||
| Article 296, Volume 27, Issue 6, November 2021, Pages 1541-1548 PDF (324.77 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zumj.2019.17660.1563 | ||
| Authors | ||
| Ola Mohamed Hadary* 1; Abd El Motaleb Ibrahim2; Shaimaa Farouk Abdelhai3; Maher Edarous4 | ||
| 1Clinical Oncology department, Faculty of medicine, Zagazig university, Zagazig, Egypt | ||
| 2Assistant Professor of Clinical oncology departement, faculty of medicine ,zagazig university, zagazig, Egypt | ||
| 3Lecturer of Nuclear Medicine, faculty of medicine ,zagazig university, zagazig, Egypt | ||
| 4Departments of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Egypt | ||
| Abstract | ||
| Background: Breast cancer is the most common malignancy in women in the world. Metastatic breast cancer (MBC) still remains incurable, and despite the many advances that have been achieved, the prognosis for those patients remains poor. Palliative RT is an efficacious treatment for ulcerative breast cancer with minimal toxicity. Aim of work: The aim of this study to retrospectively evaluate the outcomes of the 20Gy in 5 fractions and 30Gy in 10 fractions regimes in patients with advanced or metastatic breast cancer at Zagazig University. Patients and methods: This is a retrospective study on 20 patients with advanced breast cancer treated by palliative hypofraction radiotherapy at Clinical Oncology and Nuclear Medicine Department in Zagazig University Hospitals last 5 years. Data were collected retrospectively from records in last 5 years. Results: Majority of our studied groups were positive regard ER and PR, HER 2 were positive in only 12.5% and 33.3% respectively and Ki 67 were not done in majority of both groups. The local progression free survival (PFS) was not statistically significant between the two groups. The 30 Gy group received a higher equivalent dose compared to the 20 Gy group. ER status was a significant prognostic factor. This could be due to the added benefit of hormonal treatment in local control. Conclusion: The 20 Gy regime is a reasonable alternative for local control to the 30Gy regime in patients with locally advanced breast cancer. | ||
| Keywords | ||
| breast cancer; palliative hypofraction radiotherapy; Metastatic breast cancer | ||
|
Statistics Article View: 266 PDF Download: 209 |
||
